🔎 Trials Near Me

Akèy › Kansè poumon selil ti › North Carolina › Durham

Etid klinik pou Kansè poumon selil ti nan Durham, NC

9 etid pou Kansè poumon selil ti ap chèche patisipan nan sit nan ak bò kote Durham (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

Ap rekriteFaz 1/2
  • Duke University, Durham
Laj 12 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT04585750

DESTINY-PANTUMOUR04

Ap rekriteEtid obsèvasyon
  • Research Site, Durham
Laj 18 a 130 · Tout sèks · Mizajou Sep 25, 2026 · NCT07124000

A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors

Ap rekriteFaz 1/2
  • Duke Cancer Center Durham, Durham
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07488676

Study of Trilaciclib and Lurbinectidin

Ap rekriteFaz 2
  • Lineberger Comprehensive Cancer Center at University of North Carolina Chapel Hill, Chapel Hill · 10 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 21, 2026 · NCT05578326

A Study to Assess the Safety and Tolerability of BMS-986525 Alone and in Combination Therapy in Participants With Relapsed/Refractory Small Cell Lung Cancer

Ap rekriteFaz 1/2
  • Duke Cancer Institute, Durham
Laj 18 ak plis · Tout sèks · Mizajou Sep 14, 2026 · NCT07325136

A Study of Peluntamig (PT217) in Patients With Neuroendocrine Carcinomas Expressing DLL3 (the SKYBRIDGE Study)

Ap rekriteFaz 1/2
  • Duke University Medical Center, Durham
  • University of North Carolina at Chapel Hill, Chapel Hill · 10 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Jul 15, 2026 · NCT05652686

Tempus Small Cell Lung Cancer Observational Study (Sculptor)

Ap rekriteEtid obsèvasyon
  • University of North Carolina, Chapel Hill · 10 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Jun 15, 2026 · NCT05257551

Autologous CAR T-Cells Targeting the GD2 Antigen for Lung Cancer

Ap rekriteFaz 1 bonè
  • Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Feb 5, 2026 · NCT05620342

Etid Kansè poumon selil ti nan lòt vil

Lòt etid nan Durham

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.